The 31st meeting of the European Society for Hyperthermic Oncology, organized by the Hellenic Society of Oncologic Hyperthermia, took place between 21st and 23rd of June 2017. We participated at the event alongside our partner, COMBAT, which was a bronze sponsor at the Congress.
The object of the European Society for Hyperthermic Oncology (ESHO) is to promote for the public benefit, fundamental and applied research in physics, engineering, biological and clinical sciences relating to the use of hyperthermia in cancer therapy.
Moreover, the society wants to facilitate integration and exchange of information between different disciplines in the study of the biological effects of heat in the treatment of cancer either alone or combined with other cancer treatment modalities.
The European Society for Hyperthermic Oncology was established in 1987 in England. In 1992, the registered office of the Society was transferred to The Netherlands.